Anastrozole is a prescription medication that lowers estrogen levels and is sometimes prescribed off-label to address certain hormone imbalances in men, like low testosterone.
Anastrozole
*image for illustrative purpose only
Anastrozole
*image for illustrative purpose only
Anastrozole is a prescription medication primarily used to lower estrogen levels. It’s approved by the U.S. Food and Drug Administration (FDA) in some formulations to treat certain forms of breast cancer. It’s also sometimes prescribed for off-label uses to men for treating sexual health issues caused by hormonal imbalances, like low testosterone.
Anastrozole is an aromatase inhibitor, which means it blocks the enzyme responsible for converting androgens (male hormones) into estrogen. This can lead to increased testosterone levels, which may help manage conditions like gynecomastia (enlarged breast tissue in men), low testosterone, and certain cases of male infertility. Healthcare providers may also prescribe low-dose anastrozole to prevent estrogen-related side effects of testosterone replacement therapy. Other potential off-label uses for anastrozole include improving libido, treating erectile function, and elevating semen quality—but there’s much less evidence about the medication’s efficacy in these cases.
Anastrozole is typically taken as an oral tablet. Potential side effects include joint pain, fatigue, decreased bone density, and altered cholesterol levels.
Anastrozole is indicated for:
Adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer
First-line treatment of postmenopausal women with hormone receptor-positive or hormone receptor unknown locally advanced or metastatic breast cancer
Treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy
Aromatase inhibitor
In the early breast cancer (ATAC) study, the most common (occurring with an incidence of ≥10%) side effects occurring in women taking anastrozole tablets included:
Hot flashes
Weakness
Arthritis
Pain
Joint pain
Inflammation of the throat
High blood pressure
Depression
Nausea and vomiting
Rash
Osteoporosis
Fractures
Back pain
Insomnia
Headache
Peripheral swelling and lymphedema, regardless of causality
In the advanced breast cancer studies, the most common (occurring with an incidence of >10%) side effects occurring in women taking anastrozole tablets included:
Hot flashes
Nausea
Weakness
Pain
Headache
Back pain
Bone pain
Increased cough
Shortness of breath
Inflammation of the throat
Peripheral swelling
The cost of anastrozole varies depending on factors such as your insurance plan, your prescribed quantity and dosage, and where you buy it.
Without insurance, the average retail price of a dozen 1-milligram tablets of anastrozole is about $30, but coupons and discount cards are available to bring down the price as low as $2.
Arimidex®, the brand-name version of anastrozole, is more expensive. The average retail price for 30 1-milligram tablets of Arimidex is about $1,900, although coupons are available to bring down the price to about $300.
You can get a prescription for anastrozole after being evaluated by your primary care provider or another specialist who can determine if the medicine is right for you based on factors like your symptoms and medical history.
Patients with demonstrated hypersensitivity to anastrozole tablets or any excipient
Drug interactions: Tamoxifen, estrogen-containing products
In women with pre-existing ischemic heart disease, an increased incidence of ischemic cardiovascular events occurred with anastrozole tablets use compared to tamoxifen use
Decreases in bone mineral density may occur
Increases in total cholesterol may occur
Embryo-fetal toxicity: Anastrozole tablets may cause fetal harm
Females and males of reproductive potential: Verify pregnancy status prior to initiation of anastrozole tablets
Breastfeeding: Do not breastfeed
There are other prescription medications for treating low testosterone in men. Some of these drugs may be better suited to you than others. If you’re interested in finding an alternative to anastrozole for treating hormone imbalances or certain sexual health issues, talk with your provider to learn more about other medications that may work well for you. Here are some potential options:
Testosterone replacement therapy medications, including:
Androgel®
Aveed®
Azmiro®
Fortesta®
Jatenzo®
Kyzatrex®
Natesto®
Testim®
Testopel®
Tlando®
Vogelxo®
Xyosted®
Medications to increase testosterone production, including the following, which may be prescribed off-label at the discretion of a healthcare provider:
Selective estrogen receptor modulators like Clomid® (clomiphene) and Androxal® (enclomiphene)
Human chorionic gonadotropin (hCG)
Ovidrel®, a synthetic form of hCG
It can. Weight gain is listed among the potential side effects of anastrozole. That doesn’t mean the medication is guaranteed to cause weight gain, though, as each person may respond differently to the treatment.
Not enough research has been done on anastrozole for erectile dysfunction to know for sure if it’s an effective treatment option.
*This information is from the anastrozole label used by Avet Pharmaceuticals Inc. See the Full Prescribing Information for more complete information. Anastrozole may also be the active ingredient in other medications, and this information may not be accurate for all medications that include the active ingredient anastrozole.
DiGiorgio L, et al. (2016). Off label therapies for testosterone replacement. https://pmc.ncbi.nlm.nih.gov/articles/PMC5182219/
Eagle I, et al. (2017). Periodontal health in breast cancer patients on aromatase inhibitors vs. postmenopausal controls: a longitudinal analysis. https://pmc.ncbi.nlm.nih.gov/articles/PMC5614711/
GoodRx. (n.d.). Anastrozole prices, coupons, and savings tips. https://www.goodrx.com/anastrozole
GoodRx. (n.d.). Arimidex prices, coupons, and savings tips. https://www.goodrx.com/arimidex?label_override=arimidex
National Library of Medicine. (2018). Anastrozole: MedlinePlus Drug Information. https://medlineplus.gov/druginfo/meds/a696018.html
Taichman LS, et al. (2016). Periodontal health in women with early stage postmenopausal breast cancer newly on aromatase inhibitors: a pilot study. https://pmc.ncbi.nlm.nih.gov/articles/PMC4490108